Cite
HARVARD Citation
Wang, W. et al. (n.d.). 366 A randomized double-blind placebo-controlled phase III study evaluating perioperative toripalimab combined with platinum-based doublet chemotherapy in resectable stage III NSCLC. Journal for immunotherapy of cancer. p. A391. [Online].